Details of Disease

General Information of Disease (ID: DISBH6FR)

Disease Name Bordetella pertussis infection
Disease Class 1C12: Whooping cough
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISBH6FR: Bordetella pertussis infection
ICD Code
ICD-11
ICD-11: 1C12.0
ICD-10
ICD-10: A37.0
Expand ICD-11
'1C12.0
Expand ICD-10
'A37.0
Disease Identifiers
MONDO ID
MONDO_0001353
UMLS CUI
C0275742
MedGen ID
546794
SNOMED CT ID
77116006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 16 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Acel-Immune DMMPA8B Approved NA [1]
Adacel DMN3L90 Approved NA [1]
AP vaccine DM3WCXA Approved NA [1]
BK-4SP DMETF8F Approved NA [2]
Boostrix DMFZSSM Approved NA [1]
Certiva DMDJGNJ Approved NA [1]
Diphtheria, tetanus, acellular pertussis vaccine DMXDBAC Approved NA [1]
DTaP-IPV DMC29WO Approved NA [1]
DTP vaccine DMCBSE4 Approved NA [1]
Infanrix-DTaP-IPV-Hep B DM93BSN Approved NA [1]
Pentacel DM9J1CZ Approved NA [1]
Pentaxim DMA1Z5G Approved NA [1]
Quattvaxem DMGAZHU Approved Vaccine [1]
Sci-DaPT-Vac DMRUL8G Approved NA [1]
Tetraxim DMY23HI Approved NA [1]
Quadrivalent pediatric combination vaccine DM4VLLC Registered NA [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 Drug(s)
This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Actacel DMHDCF4 Phase 3 NA [4]
KD-332 DMC3M74 Phase 2 NA [5]
BPZE-1 DMRHZTY Phase 1 NA [6]
Hexavalent conjugate vaccine DMGU3MT Phase 1 NA [7]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Tetracel DM9WMZS Discontinued in Preregistration NA [8]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
DepoVax DMWLTCR Investigative NA [9]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032179)
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029525)
4 ClinicalTrials.gov (NCT01062477) A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants. U.S. National Institutes of Health.
5 ClinicalTrials.gov (NCT00831311) Study of DTaP-IPV-Hep B-PRPT Combined Vaccine Compared With PENTAXIM and ENGERIX B PEDIATRICO in Argentinean Infants. U.S. National Institutes of Health.
6 ClinicalTrials.gov (NCT02453048) Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine.
7 Protection against six childhood diseases with a hexavalent vaccine. An Pediatr.2003;58 Supl 5:41-6 - Vol. 58.
8 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005995)
9 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.